ETFChannel.com
SAVA Description — Cassava Sciences Inc

Cassava Sciences is a clinical stage biotechnology company. Co. combines technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. uses its scientific/clinical platform to develop a program for treating neurodegenerative diseases, such as Alzheimer's. Co. has two clinical-stage biopharmaceutical assets under development: its main therapeutic product candidate called simufilam for the treatment of Alzheimer's disease; and its main investigational diagnostic product candidate, called SavaDx, to detect Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Company Name: 
Cassava Sciences Inc
Website: 
www.cassavasciences.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding SAVA: 
21
Total Market Value Held by ETFs: 
$143,924,809.32
Total Market Capitalization: 
$1,757,000,000
% of Market Cap. Held by ETFs: 
8.19%
 ETF   SAVA Weight   SAVA Amount 
 VTI   0.00%   $45,456,637         
 IWM   0.06%   $38,570,127         
 VXF   0.02%   $23,553,408         
 IWO   0.11%   $13,650,768         
 XPH   2.93%   $6,622,567         
 PTH   1.13%   $5,987,498         
 VTWO   0.06%   $3,792,623         
 VTWG   0.11%   $1,668,460         
 ITOT   0.00%   $1,415,975         
 DWAS   0.19%   $855,675         
List of all 21 ETFs holding SAVA »
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
78th percentile
(ranked higher than approx. 78% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding SAVA | Cassava Sciences Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.